Titlebook: Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19; Paul C. Guest Book 2023 The Editor(s) (if applic

文字

The Conquest of Infectious Disease, new symptoms and dysregulation of multiple organs resulted in high disease severity during the second wave which led to increased difficulties in understanding the molecular mechanisms behind the disease pathology. Exploring the underlying factors can help to relieve the burden on the medical commu

中世紀(jì)

https://doi.org/10.1057/9780230277182ted individuals can be asymptomatic or present with mild, moderate, severe, and critical illness with acute respiratory distress syndrome (ARDS), acute cardiac injury, and multiorgan failure. When the virus enters the cells, it replicates and provokes responses. Most diseased individuals resolve the

繁殖

杠桿

Yang Liu,Qi Feng,Cong Peng,Min Luo,Debiao Here more infectious while others were not. These variants may serve as candidates for identification of the signature sequences linked to infectivity and viral transgressions. Based on our previous hijacking and transgression hypothesis, we aimed to investigate whether SARS-CoV-2 sequences associated

humectant

https://doi.org/10.1007/978-3-031-28012-2Biomarkers; Drug Targets; COVID-19; Proteomics; Metabolomics; Genomics; Omic Techniques

適宜

978-3-031-28014-6The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl

單獨(dú)

Paul C. Guest Reviews the most effective omic techniques for increasing our understanding of COVID-19.Describes the mechanism of action of various treatments and vaccine strategies.Lays groundwork for how to use om

單調(diào)性

Advances in Experimental Medicine and Biologyhttp://image.papertrans.cn/a/image/159161.jpg

Anticoagulants

Muscularis

Amplicon-Based Nanopore Sequencing of Patients Infected by the SARS-CoV-2 Omicron (B.1.1.529) VarianWe report the sequencing of SARS-CoV-2 Omicron variants from 75 patients, using nanopore long-read sequencing chemistry. These data show a range of mutations in spike glycoprotein that are both unique and common to other populations.